Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Scholler, Nathalie ^a   Gross, Jennifer A ^b   Garvik, Barbara ^b   Wells, Lance ^c   Liu, Yan ^b   Loch, Christian M ^b   Ramirez, Arturo B ^b   McIntosh, Martin W ^b   Lampe, Paul D ^b   Urban, Nicole ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; ELASTIN MICROFIBRIL INTERFACER 2 PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RECOMBINANT ANTIBODY; VON WILLEBRAND FACTOR; ANTIBODY; EMILIN2 PROTEIN, HUMAN; GLYCOPROTEIN; PEBP1 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TUMOR MARKER;

ANTIBODY PRODUCTION; ARTICLE; ASCITES; BIOTINYLATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ELUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPRECIPITATION; IN VIVO STUDY; MASS SPECTROMETRY; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; PARTICLE SIZE; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; YEAST; BLOOD; CANCER STAGING; CASE CONTROL STUDY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGY; OVARY TUMOR; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLUBILITY;

ANTIBODIES; BIOTINYLATION; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUBILITY; TUMOR MARKERS, BIOLOGICAL; VON WILLEBRAND FACTOR; YEASTS;

EID: 49249095372     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-41     Document Type: Article

References (45)

1. Scholler N Garvik B Quarles T Jiang S Urban N Method for generation of in vivo biotinylated recombinant antibodies by yeast mating J Immunol Methods 2006, 317:132-143 1784068 17113097
2. Feldhaus MJ Siegel RW Opresko LK Coleman JR Feldhaus JM Yeung YA Cochran JR Heinzelman P Colby D Swers J et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library Nat Biotechnol 2003, 21:163-170 12536217
3. Loch CM Ramirez AB Liu Y Sather CL Delrow JJ Garvik B Scholler N Urban N McIntosh MW Lampe PD Use of High Density Antibody Arrays to Validate and Discover Cancer Serum Biomarkers Molecular Oncology 2007, 1:313-320
4. Li C Lee KH Affinity depletion of albumin from human cerebrospinal fluid using Cibacron-blue-3G-A-derivatized photopatterned copolymer in a microfluidic device Anal Biochem 2004, 333:381-388 15450816
5. Bergan L Gross JA Nevin B Urban N Scholler N Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/ Mesothelin-dependent cell attachment Cancer Lett 2007, 255:263-274 17560019
6. Scholler N Lowe KA Bergan LA Kampani AV Ng V Forrest RM Thorpe JD Gross JA Garvik BM Drapkin R et al. Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA Clin Cancer Res 2008, 14:2647-2655 18451228
7. Rauch A Bellew M Eng J Fitzgibbon M Holzman T Hussey P Igra M Maclean B Lin CW Detter A et al. Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments J Proteome Res 2006, 5:112-121 16396501
8. Angel PM Lim JM Wells L Bergmann C Orlando R A potential pitfall in 18O-based N-linked glycosylation site mapping Rapid Commun Mass Spectrom 2007, 21:674-682 17279607
9. Craig R Beavis RC TANDEM: Matching proteins with tandem mass spectra Bioinformatics 2004, 20:1466-1467 14976030
10. MacLean B Eng JK Beavis RC McIntosh M General framework for developing and evaluating database scoring algorithms using the TANDEM search engine Bioinformatics 2006, 22:2830-2832 16877754
11. Keller A Nesvizhskii AI Kolker E Aebersold R Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 2002, 74:5383-5392 12403597
12. Scholler N Garvik B Hayden-Ledbetter M Kline T Urban N Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery Cancer Lett 2007, 247:130-136 16677756
13. Scholler N Fu N Yang Y Ye Z Goodman GE Hellstrom KE Hellstrom I Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Proc Natl Acad Sci USA 1999, 96:11531-11536 18068 10500211
14. McIntosh MW Drescher C Karlan B Scholler N Urban N Hellstrom KE Hellstrom I Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma Gynecol Oncol 2004, 95:9-15 15385104
15. Rosen DG Wang L Atkinson JN Yu Y Lu KH Diamandis EP Hellstrom I Mok SC Liu J Bast RC Jr Potential markers that complement expression of CA125 in epithelial ovarian cancer Gynecol Oncol 2005, 99:267-277 16061277
16. Spessotto P Bulla R Danussi C Radillo O Cervi M Monami G Bossi F Tedesco F Doliana R Colombatti A EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall J Cell Sci 2006, 119:4574-4584 17074837
17. Salani R Neuberger I Kurman RJ Bristow RE Chang HW Wang TL Shih Ie M Expression of extracellular matrix proteins in ovarian serous tumors Int J Gynecol Pathol 2007, 26:141-146 17413980
18. Blann AD Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years Thromb Haemost 2006, 95:49-55 16543961
19. Bast RC Jr Xu FJ Yu YH Barnhill S Zhang Z Mills GB CA 125: The past and the future Int J Biol Markers 1998, 13:179-187 10228898
20. Schummer M Ng WV Bumgarner RE Nelson PS Schummer B Bednarski DW Hassell L Baldwin RL Karlan BY Hood L Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas Gene 1999, 238:375-385 10570965
21. Hellstrom I Raycraft J Hayden-Ledbetter M Ledbetter JA Schummer M McIntosh M Drescher C Urban N Hellstrom KE The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma Cancer Res 2003, 63:3695-3700 12839961
22. Peek R Pruijn GJ van Venrooij WJ Epitope specificity determines the ability of anti-Ro52 autoantibodies to precipitate Ro ribonucleoprotein particles J Immunol 1994, 153:4321-4329 7523522
23. Matsumoto M Takeda J Inoue N Hara T Hatanaka M Takahashi K Nagasawa S Akedo H Seya T A novel protein that participates in nonself discrimination of malignant cells by homologous complement Nat Med 1997, 3:1266-1270 9359703
24. Turnberg D Botto M The regulation of the complement system: Insights from genetically-engineered mice Mol Immunol 2003, 40:145-153 12914820
25. Hakulinen J Junnikkala S Sorsa T Meri S Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form Eur J Immunol 2004, 34:2620-2629 15307194
26. Nilsson UR Mueller-Eberhard HJ Isolation of Beta If-Globulin from Human Serum and Its Characterization as the Fifth Component of Complement J Exp Med 1965, 122:277-298 2138056 14316946
27. Walport MJ Complement. First of two parts N Engl J Med 2001, 344:1058-1066 11287977
28. Horstmann RD Sievertsen HJ Knobloch J Fischetti VA Antiphagocytic activity of streptococcal M protein: Selective binding of complement control protein factor H Proc Natl Acad Sci USA 1988, 85:1657-1661 279833 2964038
29. Jarva H Jokiranta TS Wurzner R Meri S Complement resistance mechanisms of streptococci Mol Immunol 2003, 40:95-107 12914816
30. Ram S Sharma AK Simpson SD Gulati S McQuillen DP Pangburn MK Rice PA A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae J Exp Med 1998, 187:743-752 2212180 9480984
31. Pickering MC Cook HT Warren J Bygrave AE Moss J Walport MJ Botto M Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat Genet 2002, 31:424-428 12091909
32. Bjorge L Hakulinen J Vintermyr OK Jarva H Jensen TS Iversen OE Meri S Ascitic complement system in ovarian cancer Br J Cancer 2005, 92:895-905 15726105
33. Junnikkala S Hakulinen J Jarva H Manuelian T Bjorge L Butzow R Zipfel PF Meri S Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells Br J Cancer 2002, 87:1119-1127 12402151
34. Bernier I Jolles P Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain Biochim Biophys Acta 1984, 790:174-181 6435678
35. Seigneuret M Devaux PF ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes Proc Natl Acad Sci USA 1984, 81:3751-3755 345297 6587389
36. Zwaal RF Schroit AJ Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 1997, 89:1121-1132 9028933
37. Odabaei G Chatterjee D Jazirehi AR Goodglick L Yeung K Bonavida B Raf-1 kinase inhibitor protein: Structure, function, regulation of cell signaling, and pivotal role in apoptosis Adv Cancer Res 2004, 91:169-200 15327891
38. Bradley D Ratcliffe O Vincent C Carpenter R Coen E Inflorescence commitment and architecture in Arabidopsis Science 1997, 275:80-83 8974397
39. Trottein F Cowman AF The primary structure of a putative phosphatidylethanolamine-binding protein from Plasmodium falciparum Mol Biochem Parasitol 1995, 70:235-239 7637711
40. Gems D Ferguson CJ Robertson BD Nieves R Page AP Blaxter ML Maizels RM An abundant, trans-spliced mRNA from Toxocara canis infective larvae encodes a 26-kDa protein with homology to phosphatidylethanolamine-binding proteins J Biol Chem 1995, 270:18517-18522 7629180
41. Pikielny CW Hasan G Rouyer F Rosbash M Members of a family of Drosophila putative odorant-binding proteins are expressed in different subsets of olfactory hairs Neuron 1994, 12:35-49 7545907
42. Tohdoh N Tojo S Agui H Ojika K Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine-binding protein and rat 23-kDa protein associated with the opioid-binding protein Brain Res Mol Brain Res 1995, 30:381-384 7637590
43. Hengst U Albrecht H Hess D Monard D The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors J Biol Chem 2001, 276:535-540 11034991
44. Frayne J Ingram C Love S Hall L Localisation of phosphatidylethanolamine-binding protein in the brain and other tissues of the rat Cell Tissue Res 1999, 298:415-423 10639732
45. Huang LJ Chen SX Luo WJ Jiang HH Zhang PF Yi H Proteomic analysis of secreted proteins of non-small cell lung cancer Ai Zheng 2006, 25:1361-1367 17094902